Form 8-K - Current report:
SEC Accession No. 0001293971-20-000002
Filing Date
2020-01-21
Accepted
2020-01-21 16:11:08
Documents
15
Period of Report
2020-01-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blue-20200114.htm   iXBRL 8-K 45867
2 EX-10.1 exhibit10120200114.htm EX-10.1 22462
  Complete submission text file 0001293971-20-000002.txt   216259

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blue-20200114.xsd EX-101.SCH 2573
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blue-20200114_cal.xml EX-101.CAL 716
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blue-20200114_def.xml EX-101.DEF 1680
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blue-20200114_lab.xml EX-101.LAB 24265
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blue-20200114_pre.xml EX-101.PRE 12652
14 EXTRACTED XBRL INSTANCE DOCUMENT blue-20200114_htm.xml XML 11159
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02142
Business Address 60 BINNEY STREET CAMBRIDGE MA 02142 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 20536503
SIC: 2836 Biological Products, (No Diagnostic Substances)